Bernardo Lara

Process Development Scientist at Solugen

Bernardo Lara's work experience includes various roles in research, development, and quality control in the pharmaceutical and medical research fields. Bernardo worked as a Process Development Scientist at Solugen and VGXI, Inc. - GMP Plasmid DNA Manufacturing in 2023. Before that, they were an AD/PD Associate II and later a QC Analytical Specialist II at Catalent Pharma Solutions from 2021 to 2023. Prior to that, they were a Senior Research Assistant at MD Anderson Cancer Center from 2019 to 2021. Bernardo also served as a Graduate Student Researcher at UC San Diego from 2012 to 2018, focusing on stress-induced extracellular vesicles. Their early experience includes roles as a Laboratory Assistant at Millennium Laboratories in 2012, a Research Intern at Sanford-Burnham Medical Research Institute from 2010 to 2012, and a Research Assistant in Translational Research in Kidney Disease at UC San Diego in 2009.

Bernardo Lara began their education at UC San Diego in 2010, where they pursued a Bachelor of Science degree in Biochemistry and Cell Biology. Bernardo completed this program in 2012. Continuing their studies, Bernardo Lara then enrolled in a Master of Science program in Biomedical Sciences, General at UC San Diego in 2012. Bernardo successfully completed this program in 2018.

Location

Houston, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Solugen

2 followers

Solugen is a venture-backed biotech startup that produces high-performance chemicals from plant-derived substitutes. Our award-winning hydrogen peroxide technology was developed in-house by a team of doctors, scientists, and engineers from MIT. Solugen is a manufacturer and supplier of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. We challenge the traditional approach to chemicals production, which is capital intensive, dangerous, environmentally unfriendly and largely unchanged since 1942. Our patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.


Employees

51-200

Links